Desktop Scanners
PRODUCTS
-
We believe that QMS software should adapt to you — not the other way around. ETQ Reliance® is more than just QMS software — it’s a comprehensive quality management software system designed to streamline and elevate every aspect of your organization’s quality processes.
-
Designed for versatility throughout the bioproduction workflow with patented performance of Metenova® Zero Gravity mixing technology, now optimized for single-use applications. This cutting edge system offers unmatched performance, ease of use, and scalability for both Upstream and Downstream bioprocessing professionals seeking cost-effective, efficent, and easy-to-deploy solutions.
-
The QPM0106 is a packaged, high-power amplifier fabricated on Qorvo's production 0.25 um GaN on SiC process that operates from 1.0 - 6.0 GHz and provides 45.4 dBm (35 W) of saturated output power.
-
The MPA3013 is a high-performance medium power amplifier designed for applications requiring a wide operating frequency range and significant output power in a compact form factor.
-
Enables secure real-time document review, co-authoring, and redaction in order to shorten the document review process by up to 65%.
WHITE PAPERS AND CASE STUDIES
-
Using Plant Peptones To Boost Plasmid Yield And Induction
Uncover how Nu‑Tek’s plant-based peptones support E. coli growth, plasmid yield, and controlled induction, offering a sustainable, animal-free alternative for biopharmaceutical cell culture.
-
Methods For Determining Equipment Capability Of Freeze-Dryers
Observe two experimental methods for determining choked flow: the minimum controllable pressure method and the choke point method.
-
Vial Fogging: Practical Considerations For Vial Selection
Vial fogging is a common phenomenon observed in lyophilized biologic drug products. This document presents two case studies that explore critical factors contributing to vial fogging and inform vial selection decisions.
-
eCOA: Unified Approach Streamlines Processes, Speeds Start Up And Improves Data Quality
Discover how a leading biopharmaceutical company revolutionized its clinical development with an eCOA solution that optimized its processes, cut build times, and enhanced data quality.
-
2nd Generation ATAD Provides High Quality Biosolids With Increased Capacity
Modernize solids handling with automated aerobic digestion to manage rapid community growth. This high-rate process increases capacity, ensures Class A compliance, and significantly reduces disposal costs while providing odor-free operations through advanced nutrient and off-gas management.
-
Navigating The European Market's Regulatory Complexities
Prepare your EU launch strategy with this comprehensive guide detailing what is needed to ensure compliance and efficiency in the EU market.
-
MBR Solutions For Modern Industries
This white paper will explore advanced, sustainable wastewater management systems that align with your business's growth trajectories and emergent needs.
-
Physiologix™ Serum Replacement Performance On Mesenchymal Stem Cells
Learn about the effectiveness of a xeno-free serum replacement in mesenchymal stem cell (MSC) culture and its potential to enhance cell growth and reduce variability compared to fetal bovine serum.
-
3-Week Database Builds That Withstood FDA Review
Learn how a lean clinical team deployed global, regulator-ready databases in just three weeks to secure immediate Phase 3 entry and transform reproductive health research.
-
Next-Generation Fluorescence-Based Life Science Instrument
Next-gen fluorescence imaging prototype delivers compact, multi-color LED/laser illumination, high-precision optics, robust motion control, and validated imaging performance, ensuring superior sensitivity, stability, and repeatable results.
-
AAV-Based Gene Editing For Huntington's Disease
LETI-101 uses AAV5 to deliver a compact CRISPR system for allele-selective editing of mutant HTT, showing promise as a one-time treatment for Huntington’s disease with strong preclinical safety and efficacy.
-
Quality By Design: Better Data Using Participant Insights
While clinical trials will always encounter challenges in driving quality experiences and data, there is one approach that’s backed by regulatory agencies and proven to lead to better outcomes.
NEWS
-
Ericsson Unveils New Wave Of Radio, Antenna, And RAN Connect Products To Advance High-Performing Programmable Networks2/12/2025
As telecoms industry engagement with high-performing programmable networks ramps up globally, Ericsson is meeting related future needs through a significant product portfolio boost.
-
Simbe Expands Next-Generation Computer Vision Technology To Transform Retail Execution5/20/2025
Simbe, the global leader in shelf digitization, today announced significant advancements to Simbe Vision™, its AI-powered computer vision (CV) technology, further solidifying the company's position as the retail industry's most advanced in-store intelligence solution.
-
Siemens Receives Frost & Sullivan's 2025 Europe, Middle East, And Africa Company Of The Year Award For Excellence In Smart Water Meter Data Management7/1/2025
Frost & Sullivan is pleased to announce that Siemens has been awarded the 2025 Europe, Middle East, and Africa Company of the Year Award in the smart water meter data management (MDM) industry for its outstanding achievements in digital innovation, operational efficiency, and customer impact. This recognition highlights Siemens's leadership in delivering intelligent, scalable, and vendor-agnostic water MDM solutions that help utilities optimize operations, engage customers, and support long-term sustainability.
-
The Granite Group Partners With FieldPulse To Supply Field Service Management Software To Contractors2/14/2025
The Granite Group has enhanced its partnership with FieldPulse to now include system integration.
-
ArriVent BioPharma Enters Exclusive License With Lepu Biopharma For MRG007, An Antibody Drug Conjugate For The Treatment Of Gastrointestinal Cancers1/21/2025
ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP) a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that it has entered into an exclusive license agreement with Lepu Biopharma Co., Ltd (Stock Code: 02157.HK) for MRG007, an antibody-drug conjugate (ADC) that can target several gastrointestinal (GI) cancers.